 | Lumos Pharma, Inc. | |||
| NGM : LUMO || Location: United States | ||||
$2.68+0.09 (+3.47%) |
0.0 M | 2.6 - 2.7 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.287 M |
| March 15, 2024 | 0.294 M |
| Feb. 29, 2024 | 0.298 M |
| Feb. 15, 2024 | 0.297 M |
| Jan. 31, 2024 | 0.290 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.17 | -1.17 | 0.26% |
| 09/30/2023 | -1.17 | -1.04 | 11.19% |
| 06/30/2023 | -1.12 | -1.09 | 2.56% |
| 03/31/2023 | -1.15 | -0.89 | 22.32% |
| 12/31/2022 | -0.95 | -0.99 | -4.18% |
LUMO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 8.107M | Shares Float | 5.303M |
| Short Float | 0.287M | Market Cap | 21.73M |
| Institution ownership | 29.30% | Insider ownership | 34.833% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -4.18 | Forward EPS | -2.01 |